You are here

Kanserojen Ajanlar için Optimum Güvenli Doz Tahmini (Simulated veri kullanma A Case Study) (Seri C)

Optimum Safe Dose Estimation for Carcinogenic Agents (A Case Study Using Simulated Data) (Series C)

Journal Name:

Publication Year:

Author NameFaculty of Author
Abstract (2. Language): 
In this paper we introduce one procedure to estimate safe doses, named exposed or administered dose, for carcinogenic or toxical materials. The model, relying on statistical distribution takes into account a major assumption, which is explained below. *The probabilistic model underlying the waiting time of occurrence (such as tumor occurrence, etc.) is a renewal Weibull Process. The literature on the topic is full of various models, using different assumptions. Most of these models consider the administered dose as effective dose, the derived model is built on this basis, and the safe doses are estimated using extrapolations near low risk doses. Under this assumption we can reach a model different from the ones used before. Our derived model will be our working model in order to estimate the administered safe dose i;. We intend to estimate x using the final model. At the end of the study, we have estimated optimum safe dose to apply the procedure by using simulated data on computer according to the underlying model and distribution.
Abstract (Original Language): 
Bu çalışmada, kanserojen ve toksik maddeler için, maruz kalınan veya idare edilen doz olarak da adlandırılan, güvenli dozu tahmin etmek için yeni bir model tanıtıldı. Bu model, aşağıda açıklanan varsayımı temel almaktadır. "Olasılıksal modelin temeli, meydana gelme bekleme zamanının yinelenen Weibull süreci olmasına dayanmaktadır.Literatürde, bu konu için farklı varsayımlar kullanılarak elde edilen çeşitli modeller bulunmaktadır. Yukarıda tanımlanan varsayım altında bulunan model literatürde daha önce tanımlanan modellerden oldukça farklıdır. Bulunan model ile maruz kalınan en güvenli doz i;. için tahmin edici elde edilmiştir. Çalışmanın sonunda, simülasyon yolu ile elde edilen veriler modelimizde kullanlılarak optimum güvenli doz tahmin edilmiştir.
93-106

REFERENCES

References: 

C. Lu Frank, Jr.R.L.Sielken, 'Assessment of safety/risk of chemicals: inception and evolution of the ADI and dose
response modeling procedures', Toxicology Letters, 59(1991), pp.5-40.
D. D.Boss, C.Brownie, 'Mixture Models for Continuous Data in Dose-Response Studies When Some Animals are
Unaffected by Treatment', Biometrics, 47(1991), pp.1489-1504. H.O.Hartley, Jr.R.L.Sielken, 'Estimation of "Safe Doses" in Carcinogenic Experiments', Biometrics, 33(1977), pp.1-30.
Jr.R.L.Sielken, 'Useful Tools for Evaluating and Presenting More Science in Quantitative Cancer Risk
Assessments', Toxic Substances Journal, 9(1989), pp.353-404. Jr.R.L.Sielken, 'Incorporating More Science into Cancer Dose-Response Extrapolations, Toxic Substances Journal,
11(1990), pp.87-94.
J.Van
Ryzin
, K. Rai, The Use of Quantal Response Data to Make Predictions, in The Scientific Basis of Toxicity
Assessment (New York: Elsevier North-Holland, 1979). L.J.Bain, M. Engelhardt, Statistical Analysis of Reliability and Life Testing Models Theory and Methods (New
York: Marcel Dekker, inc, 1991). M.W. Anderson, D.G. Hoel, N.L.Kaplan, 'A General Scheme for the Incorporation of Pharmacokinetics in Low-
Dose Risk Estimation for Chemical Carcinogenesis: Example-Vinly Chloride', Toxicology and Applied
Pharmacology, 55(1980), pp.154-161. M.D.Finkelstein, A.D.Schoenfeld, 'Analysis of Multiple Tumor Data from a Rodent Carcinogenicity Experiment',
Biometrics, 45(1989), pp.219-230. N.E. Day, 'The Armitage-Doll Multistage Model of Carcinogenesis', Statistics of Medicine, 9(1990), pp.677-679. P.Armitage,'The Assessment of Low-Dose Carcinogenicity', Biometrics, supplement (1982), pp.19-129. P.Armitage, R.Doll, 'A Two-Stage Theory of Carcinogenesis in relation to the age Distribution of Human Cancer',
British Journal of Cancer, 8(1957) pp.1-12.
106

Thank you for copying data from http://www.arastirmax.com